Skip to main content

Baird Venture Partners Raises $90 Million VC Fund

NEW YORK, Aug. 13 (GenomeWeb News) - Baird Venture Partners of Milwaukee, Wisc., announced yesterday an investment of $30 million by the pension fund SWIB (State of Wisconsin Investment Board), and the second closing on a $90 million pool of capital for investment in regional ventures including life sciences and healthcare. 

   

The firm already holds investments in microarray-and-services provider NimbleGen Systems of Madison, Wisc., and  TomoTherapy, also of Madison, as well as investments in firms in Texas, California, and Illinois.

   

New BVP investors include, among others, The State of Wisconsin Investment Board (SWIB), Wisconsin Alumni Research Foundation (WARF), Lurie Investments Inc., The Northwestern Mutual Life Insurance Company, Johnson Financial Group, the Helen Bader Trusts, Robert W. Baird & Co., and a group of angel investors.

 

 

 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.